A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Table 3. Notification rates of diseases, 1 April to 30 June 2007, by state or territory. (Annualised rate per 100,000 population)
Disease* |
State or territory | Aust | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ACT | NSW | NT | Qld | SA | Tas | Vic | WA | ||
Bloodborne diseases |
|||||||||
| Hepatitis B (incident) | 2.4 |
0.9 |
9.7 |
1.4 |
0 |
0.8 |
1.4 |
2.3 |
1.3 |
| Hepatitis B (unspecified) | 13.4 |
46.2 |
83.2 |
27.2 |
21.9 |
4.1 |
34 |
31.4 |
35 |
| Hepatitis C (incident) | 1.2 |
0.5 |
0 |
NN |
1.8 |
2.5 |
1.9 |
3.5 |
1.5 |
| Hepatitis C (unspecified) | 46.2 |
89.9 |
106.4 |
68.6 |
19.8 |
44.2 |
52.1 |
51.7 |
65.6 |
| Hepatitis D | 0 |
0.2 |
0 |
0.2 |
0 |
0 |
0.2 |
0 |
0.2 |
Gastrointestinal diseases |
|||||||||
| Botulism | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Campylobacteriosis† | 126.5 |
NN |
189.7 |
97.5 |
169.3 |
134.2 |
106.7 |
87.4 |
110.8 |
| Cryptosporidiosis | 2.4 |
4.7 |
69.7 |
8.4 |
20.8 |
5.7 |
11.7 |
32.2 |
11.8 |
| Haemolytic uraemic syndrome | 0 |
0.1 |
0 |
0 |
0 |
0 |
0.2 |
0 |
0.1 |
| Hepatitis A | 0 |
0.7 |
1.9 |
0.9 |
0.3 |
0.8 |
0.4 |
2 |
0.8 |
| Hepatitis E | 0 |
0 |
0 |
0.2 |
0 |
0 |
0.3 |
0 |
0.1 |
| Listeriosis | 0 |
0.3 |
0 |
0 |
0 |
0.8 |
0.2 |
0 |
0.2 |
| Salmonellosis (NEC) | 36.5 |
36.1 |
228.4 |
65.7 |
48.1 |
38.4 |
37.4 |
42.1 |
45.8 |
| Shigellosis | 0 |
0.9 |
75.5 |
1 |
3.3 |
1.6 |
2 |
4.9 |
2.5 |
| SLTEC, VTEC‡ | 0 |
0.1 |
0 |
0.3 |
1.3 |
0 |
0.2 |
0 |
0.2 |
| Typhoid | 0 |
0.6 |
0 |
0.1 |
0 |
0 |
0.4 |
0 |
0.3 |
Quarantinable diseases |
|||||||||
| Cholera | 0 |
0.1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Plague | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Rabies | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Smallpox | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Tularemia | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Viral haemorrhagic fever | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Yellow fever | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Sexually transmissible infections |
|||||||||
| Chlamydial infection§ | 270.1 |
167.3 |
1341.2 |
306.7 |
196.3 |
234 |
193.8 |
343.9 |
236 |
| Donovanosis | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Gonococcal infection | 10.9 |
20.6 |
1035.4 |
34.4 |
38.6 |
7.4 |
18.1 |
80 |
39.7 |
| Syphilis (all) | 7.3 |
18.2 |
172.2 |
9.5 |
3.1 |
8.2 |
15.3 |
9.4 |
14.9 |
| Syphilis <2 years duration | 0 |
3.5 |
121.9 |
5.3 |
0.3 |
3.3 |
6.4 |
5.9 |
5.7 |
| Syphilis >2 years or unspecified duration | 7.3 |
14.7 |
50.3 |
4.1 |
2.8 |
4.9 |
8.9 |
3.5 |
9.2 |
| Syphilis - congenital | 0 |
0.1 |
3.9 |
0 |
0 |
0 |
0 |
0 |
0.1 |
Vaccine preventable diseases |
|||||||||
| Diphtheria | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Haemophilus influenzae type b | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.4 |
0 |
| Influenza (laboratory confirmed) | 7.3 |
8.9 |
13.5 |
20.2 |
2.6 |
11.5 |
2.6 |
18.5 |
10.1 |
| Measles | 0 |
0.1 |
0 |
0.1 |
0 |
0 |
0.1 |
0 |
0.1 |
| Mumps | 0 |
3.1 |
23.2 |
0.8 |
1.3 |
0 |
0.6 |
0.2 |
1.7 |
| Pertussis | 29.2 |
24.6 |
11.6 |
33 |
24.2 |
4.1 |
22.2 |
3.7 |
23 |
| Pneumococcal disease (invasive) | 9.7 |
6.4 |
32.9 |
6.8 |
8.7 |
2.5 |
5.8 |
5.9 |
6.7 |
| Poliomyelitis | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Rubella | 1.2 |
0.3 |
0 |
0.4 |
0.3 |
0 |
0.2 |
0.2 |
0.3 |
| Rubella - congenital | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Tetanus | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Varicella infections (chickenpox) | NDP |
NN |
32.9 |
4.3 |
41.9 |
0.8 |
NN |
7.8 |
12.7 |
| Varicella infections (unspecified) | NDP |
NN |
31 |
7.8 |
41.7 |
14.7 |
NN |
13.5 |
16.5 |
| Varicella zoster infections | NDP |
NN |
3.9 |
71 |
18.8 |
5.7 |
NN |
29.8 |
45.7 |
Vectorborne diseases |
|||||||||
| Barmah Forest virus infection | 4.9 |
13.6 |
61.9 |
24.1 |
2.8 |
0 |
0.7 |
3.5 |
10.7 |
| Dengue | 1.2 |
0.9 |
5.8 |
4.1 |
1 |
0 |
0.2 |
2 |
1.5 |
| Flavivirus infection (NEC) | 0 |
0 |
0 |
0.6 |
0 |
0 |
0.1 |
0 |
0.1 |
| Japanese encephalitis virus | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Kunjin virus | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Malaria | 1.2 |
1 |
17.4 |
6 |
2.8 |
1.6 |
3 |
5.5 |
3.2 |
| Murray Valley encephalitis virus | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Ross River virus infection | 4.9 |
16.3 |
129.7 |
70.9 |
13.1 |
1.6 |
1.7 |
23 |
24.5 |
Zoonoses |
|||||||||
| Anthrax | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Australian bat lyssavirus | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Brucellosis | 0 |
0 |
0 |
0.4 |
0 |
0 |
0 |
0.2 |
0.1 |
| Leptospirosis | 0 |
0.1 |
0 |
2.2 |
0.3 |
0 |
0.2 |
0.4 |
0.5 |
| Lyssavirus unspecified | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Ornithosis | 0 |
0.6 |
0 |
0 |
0 |
0 |
1.2 |
0 |
0.5 |
| Q fever | 0 |
2.8 |
1.9 |
3 |
2.8 |
0 |
0.7 |
0.4 |
1.9 |
Other bacterial infections |
|||||||||
| Legionellosis | 2.4 |
1.5 |
3.9 |
1.5 |
2.1 |
0.8 |
1.3 |
2 |
1.6 |
| Leprosy | 0 |
0.1 |
0 |
0.2 |
0.3 |
0 |
0 |
0.2 |
0.1 |
| Meningococcal infection|| | 0 |
1.3 |
3.9 |
0.7 |
0.8 |
0.8 |
1.7 |
0.4 |
1.1 |
| Tuberculosis | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
* Rates are subject to retrospective revision.
† Not reported for New South Wales where it is only notifiable as ‘foodborne disease’ or ‘gastroenteritis in an institution’.
‡ Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (SLTEC/VTEC).
§ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for South Australia which reports
only genital tract specimens, Northern Territory which excludes ocular specimens, and Western Australia which excludes ocular and perinatal infections.
|| Only invasive meningococcal disease is nationally notifiable. However, New South Wales, the Australian Capital Territory and South Australia also report
conjunctival cases.
NN Not notifiable.
NEC Not elsewhere classified.
NA Not applicable.
NDP No data provided.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 31 No 3, September 2007
Communicable Diseases Intelligence